Emma Greenwood (FCIM)

Global Marketing Director at Sterling Pharma Solutions

Emma Greenwood has a diverse work experience spanning multiple industries and roles. Emma started their career in 2002 as a Communications Manager at Banks Developments and later joined VolkerStevin in the same role. In 2009, they became the Head of Corporate Communications at VolkerWessels UK, where they managed marketing communications, brand development, and internal communications. Emma served as the Vice Chair of the North East Regional Board at CIM | The Chartered Institute of Marketing from 2016 to 2018. Emma also worked as a Tutor at nesma North East Sales and Marketing Academy from 2017 to 2018. Emma gained experience as a Marketing Specialist at The Crown Inn, Elton from 2016 to 2020. Their most recent role was as a Director - BEL Enterprises at British Engines, where they played a critical role in the development and growth of multiple businesses within the group. Since 2020, Emma has been appointed as the Marketing Director at Sterling Pharma Solutions.

Emma Greenwood (FCIM) has a strong educational background in marketing and leadership development. Emma completed a Postgraduate Diploma in Marketing from the CIM | The Chartered Institute of Marketing in 2004-2006. Later, in 2007-2009, they pursued a Chartered Marketer qualification from the same institute. In 1995-1998, they graduated with a BA Hons degree in Media & Management from Leeds Trinity University. Emma also has experience in leadership development, as they attended the VolkerWessels UK Academy in 2012-2013, where they obtained a degree in Leadership Development.

Location

Romford, United Kingdom

Links

Previous companies


Org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


Sterling Pharma Solutions

1 followers

Sterling Pharma Solutions has over 50 years' experience serving the global pharmaceutical industry. Our facilities are located in Cramlington and Newcastle Biosphere, UK; Deeside, Wales; Cork, Ireland, as well as North Carolina and Wisconsin in the US. Our state-of-the-art facilities, proprietary technologies and experienced people are among the best in the industry. We have a proven track record in the supply of chemistry and analytical services across the entire product lifecycle, from grams to tonnes, from pre-clinical to commercial supply. Our world-class safety and quality standards are globally recognised and demonstrated through successful MHRA and FDA inspections and CIA Gold Awards for Safety the last three consecutive years. We pride ourselves on our customer focus and service approach, offering flexible, tailored solutions to our customers. In addition, our North Carolina and Newcastle Biosphere facilities offer expert chemistry solutions for small volume batches or products in the early stages of clinical trials. Our Deeside, Wales facility provide bioconjugation development services and specialised in antibody drug conjugation (ADC) research and development. Find out more: www.sterlingpharmasolutions.com/sterling-facilities


Industries

Employees

1,001-5,000

Links